| Dr Mehmet Sitki Copur, MD | |
|
2116 West Faidley Avenue Suite 200, Grand Island, NE 68803-4671 | |
| (308) 398-5450 | |
| Not Available |
| Full Name | Dr Mehmet Sitki Copur |
|---|---|
| Gender | Male |
| Speciality | Medical Oncology |
| Experience | 42 Years |
| Location | 2116 West Faidley Avenue Suite 200, Grand Island, Nebraska |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1871517433 | NPI | - | NPPES |
| 47037660113 | Medicaid | NE |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mary Lanning Healthcare | Hastings, NE | Hospital |
| York General Hospital | York, NE | Hospital |
| The Nebraska Medical Center | Omaha, NE | Hospital |
| Howard County Medical Center | St paul, NE | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| The Mary Lanning Memorial Hospital Association | 4587575550 | 117 |
News Archive
Unigene Laboratories, Inc. today announced that the Company entered into an amended and restated exclusive worldwide license agreement with GlaxoSmithKline (GSK) to develop and commercialize an oral formulation of a recombinantly produced parathyroid hormone (PTH) analog for the treatment of osteoporosis in postmenopausal women and plans to initiate a Phase 2 study in the first quarter of 2011.
The co-authors are employees of the Protein-Cell Interactions Lab of Kazan Federal University (Natalia G. Evtugina, Alina D. Peshkova, and Lab Head Rustem I. Litvinov) in cooperation with Interregional Clinical Diagnostic Center, Kazan, Russia (Arseniy A. Pichugin) and University of Pennsylvania (John W. Weisel and Rustem I. Litvinov by his primary employment).
For the first time, researchers at The Westmead Institute for Medical Research have identified and described a new and unique subset of human cells that are involved in the immune response against hepatitis B (HBV) infection. The discovery could help develop new treatments for HBV and inform future vaccine design.
MAQUET Cardiovascular LLC, a leading provider of cardiovascular technologies, today announced the initiation of the OPTION (Optimal Improvement of Vein Graft Patency Long Term by the Implementation Of Novel Endoscopic Harvesting Techniques) study. This clinical trial is designed to evaluate the equivalence of Endoscopic Vessel Harvesting (EVH) in Coronary Artery Bypass Graft (CABG) surgery compared with historical data for open vein harvesting. David Moore, M.D., of THE HEART HOSPITAL Baylor Plano is the principal investigator for the OPTION trial.
Women seeking to overcome an eating disorder or addiction still face numerous hurdles once they acknowledge their disease and commit to pursuing a path of recovery. Women with advanced or multiple interconnected diseases often seek inpatient or residential treatment, which gives them time to step back from the demands of daily life to focus solely on themselves.
› Verified 6 days ago
| Entity Name | The Mary Lanning Memorial Hospital Association |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588812796 PECOS PAC ID: 4587575550 Enrollment ID: O20080922000295 |
News Archive
Unigene Laboratories, Inc. today announced that the Company entered into an amended and restated exclusive worldwide license agreement with GlaxoSmithKline (GSK) to develop and commercialize an oral formulation of a recombinantly produced parathyroid hormone (PTH) analog for the treatment of osteoporosis in postmenopausal women and plans to initiate a Phase 2 study in the first quarter of 2011.
The co-authors are employees of the Protein-Cell Interactions Lab of Kazan Federal University (Natalia G. Evtugina, Alina D. Peshkova, and Lab Head Rustem I. Litvinov) in cooperation with Interregional Clinical Diagnostic Center, Kazan, Russia (Arseniy A. Pichugin) and University of Pennsylvania (John W. Weisel and Rustem I. Litvinov by his primary employment).
For the first time, researchers at The Westmead Institute for Medical Research have identified and described a new and unique subset of human cells that are involved in the immune response against hepatitis B (HBV) infection. The discovery could help develop new treatments for HBV and inform future vaccine design.
MAQUET Cardiovascular LLC, a leading provider of cardiovascular technologies, today announced the initiation of the OPTION (Optimal Improvement of Vein Graft Patency Long Term by the Implementation Of Novel Endoscopic Harvesting Techniques) study. This clinical trial is designed to evaluate the equivalence of Endoscopic Vessel Harvesting (EVH) in Coronary Artery Bypass Graft (CABG) surgery compared with historical data for open vein harvesting. David Moore, M.D., of THE HEART HOSPITAL Baylor Plano is the principal investigator for the OPTION trial.
Women seeking to overcome an eating disorder or addiction still face numerous hurdles once they acknowledge their disease and commit to pursuing a path of recovery. Women with advanced or multiple interconnected diseases often seek inpatient or residential treatment, which gives them time to step back from the demands of daily life to focus solely on themselves.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Mehmet Sitki Copur, MD 2116 West Faidley Avenue Suite 200, Grand Island, NE 68803-4671 Ph: (308) 398-5450 | Dr Mehmet Sitki Copur, MD 2116 West Faidley Avenue Suite 200, Grand Island, NE 68803-4671 Ph: (308) 398-5450 |
News Archive
Unigene Laboratories, Inc. today announced that the Company entered into an amended and restated exclusive worldwide license agreement with GlaxoSmithKline (GSK) to develop and commercialize an oral formulation of a recombinantly produced parathyroid hormone (PTH) analog for the treatment of osteoporosis in postmenopausal women and plans to initiate a Phase 2 study in the first quarter of 2011.
The co-authors are employees of the Protein-Cell Interactions Lab of Kazan Federal University (Natalia G. Evtugina, Alina D. Peshkova, and Lab Head Rustem I. Litvinov) in cooperation with Interregional Clinical Diagnostic Center, Kazan, Russia (Arseniy A. Pichugin) and University of Pennsylvania (John W. Weisel and Rustem I. Litvinov by his primary employment).
For the first time, researchers at The Westmead Institute for Medical Research have identified and described a new and unique subset of human cells that are involved in the immune response against hepatitis B (HBV) infection. The discovery could help develop new treatments for HBV and inform future vaccine design.
MAQUET Cardiovascular LLC, a leading provider of cardiovascular technologies, today announced the initiation of the OPTION (Optimal Improvement of Vein Graft Patency Long Term by the Implementation Of Novel Endoscopic Harvesting Techniques) study. This clinical trial is designed to evaluate the equivalence of Endoscopic Vessel Harvesting (EVH) in Coronary Artery Bypass Graft (CABG) surgery compared with historical data for open vein harvesting. David Moore, M.D., of THE HEART HOSPITAL Baylor Plano is the principal investigator for the OPTION trial.
Women seeking to overcome an eating disorder or addiction still face numerous hurdles once they acknowledge their disease and commit to pursuing a path of recovery. Women with advanced or multiple interconnected diseases often seek inpatient or residential treatment, which gives them time to step back from the demands of daily life to focus solely on themselves.
› Verified 6 days ago
Dr. Niraj Kumar Yadav, MBBS Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 2620 W Faidley Ave, Grand Island, NE 68803 Phone: 308-384-4600 | |
Dr. Nathan William Murdoch, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3610 Richmond Cir Ste 100, Grand Island, NE 68803 Phone: 308-398-6400 Fax: 308-398-6408 | |
Dr. Clayton Jose Friesen, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3515 Richmond Circle, Grand Island, NE 68803 Phone: 308-381-8636 Fax: 308-381-8622 | |
Dr. Ghulam R. Mirza, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 2201 N Broadwell Ave, Grand Island, NE 68803 Phone: 308-382-3660 | |
Swathi Lavudi, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3563 Prairieview St Ste 200, Grand Island, NE 68803 Phone: 308-382-2010 Fax: 308-382-9549 | |
Dr. John A Wagoner, M.D. Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 800 N Alpha St, Grand Island, NE 68803 Phone: 308-382-2010 Fax: 308-382-9549 | |
Dr. Jeffrey K. King, M.D. Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 3515 Richmond Circle, Grand Island, NE 68803 Phone: 308-381-8636 Fax: 308-381-8622 |